VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,816,765 | -72.8% | 727,615 | -28.9% | 0.00% | -75.0% |
Q2 2023 | $25,090,503 | +2290.8% | 1,022,739 | +2167.7% | 0.01% | – |
Q1 2023 | $1,049,477 | +91878.7% | 45,100 | 0.0% | 0.00% | – |
Q4 2022 | $1,141 | -99.9% | 45,100 | 0.0% | 0.00% | – |
Q3 2022 | $870,000 | -70.9% | 45,100 | -61.6% | 0.00% | -100.0% |
Q2 2022 | $2,989,000 | -81.0% | 117,379 | -80.8% | 0.00% | -80.0% |
Q1 2022 | $15,749,000 | +17.3% | 612,336 | +91.0% | 0.01% | +25.0% |
Q4 2021 | $13,421,000 | +499.2% | 320,551 | +522.6% | 0.00% | +300.0% |
Q3 2021 | $2,240,000 | +25.7% | 51,482 | +36.6% | 0.00% | 0.0% |
Q2 2021 | $1,782,000 | -27.7% | 37,689 | -21.6% | 0.00% | 0.0% |
Q1 2021 | $2,465,000 | +833.7% | 48,070 | +387.0% | 0.00% | – |
Q4 2020 | $264,000 | -19.8% | 9,870 | +2.9% | 0.00% | – |
Q3 2020 | $329,000 | – | 9,596 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |